北方國際(000065.SZ):擬按每10股配售不超3股募資不超12億元
格隆匯8月11日丨北方國際(000065.SZ)發佈202年度配股公開發行股票預案,擬按每10股配售不超過3股的比例向全體股東配售。若以公司截至2021年3月31日的總股本769,540,329 股為基數測算,此次可配股數量為不超過 230,862,098股。
公司控股股東中國北方工業有限公司及其一致行動人北方工業科技有限公司承諾將按其持股比例以現金方式全額認購此次配股方案中的可配售股份。
此次配股擬募集資金總額不超過人民幣12億元(含發行費用),扣除發行費用後的淨額將全部用於補充公司流動資金與償還借款。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.